Abordaje y actualización sobre el consumo de cannabis en la población española

Referencias bibliográficas

• Calakos, K. C., Bhatt, S., Foster, D. W. y Cosgrove, K. P. (2017). Mechanisms underlying sex differences in cannabis use. Current addiction reports, 4(4), 439–453. https:// doi.org/10.1007/s40429-017-0174-7
• Chabrol, H., Massot, E., Montovany, A., Chouicha, K. y Armitage, J. (2002). Modes de consommation, représentations du cannabis et dépendance: Étude de 159 adolescents consommateurs. Archives de Pédiatrie, 9, 780-788. https://doi. org/10.1016/S0929-693X(01)00989-7
• Chabrol, H., Roura, C. y Armitage, J. (2003). Bongs, a method of using cannabis linked to dependence. The Canadian Journal of Psychiatry, 48, 709-709. https://doi. org/10.1177/070674370304801011
• Clausen, L., Hjorthøj, C. R., Thorup, A., Jeppesen, P., Petersen, L., Bertelsen, M. y Nordentoft, M. (2014). Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial. Psychological Medicine, 44(1), 117-126. https://doi. org/10.1017/S0033291713000433
• Colizzi, M. y Bhattacharyya, S. (2017). Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition. Current Addiction Reports, 4, 62-74. https:// doi.org/10.1007/s40429-017-0142-2
• Darawshy, F., Abu, A., Kuint, R. y Berkman, N. (2021). Waterpipe smoking: A review of pulmonary and health effects. European Respiratory Review: An Official Journal of the European Respiratory Society, 30. https://doi. org/10.1183/16000617.0374-2020
• Davis, C. y Fattore, L. (2015). Gender differences in cannabis addiction and dependence. En P. Campolongo y L. Fattore (Eds.), Cannabinoid modulation of emotion, memory, and motivatio (pp. 283-325). Springer.
• Davis, G. P., Compton, M. T., Wang, S., Levin, F. R. y Blanco, C. (2013). Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophrenia research, 151(1-3), 197-202. https:// doi.org/10.1016/j.schres.2013.10.018
• Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., ... & van der Ven, E. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry, 6(5), 427-436. https://doi.org/10.1016/ S2215-0366(19)30048-3
• Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., Dazzan, P., Mondelli, V., Paparelli, A., Kolliakou, A., Prata, D., Gaughran, F., David, A. S., Morgan, C., Stahl, D., Khondoker, M., … Murray, R. M. (2014). Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophrenia bulletin, 40(6), 1509–1517. https://doi.org/10.1093/ schbul/sbt181
• Ehlers, C. L., Gizer, I. R., Vieten, C., Gilder, D. A., Stouffer, G. M., Lau, P. y Wilhelmsen, K. C. (2010). Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. Addictive behaviors, 35(2), 102-110.
• ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S. y Church, J.C. (2016). Changes in cannabis potency over the last 2 decades (1995-2014): Analysis of current data in the United States. Biological Psychiatry, 79, 613- 619. https://doi. org/10.1016/j.biopsych.2016.01.004
• García-Couceiro, N., Isorna, M., Braña, T., Varela, J., Gandoy-Crego, M. y Rial, A. (2022). El uso de la cachimba entre los adolescentes. Posibles implicaciones y variables asociadas. Adicciones. http:// dx.doi.org/10.20882/adicciones.1744
• Goldsmith, R. S., Targino, M. C., Fanciullo, G. J., Martin, D. W., Hartenbaum, N. P., White, J. M. y Franklin, P. (2015). Medical marijuana in the workplace: Challenges and management options for occupational physicians. Journal of Occupational and Environmental Medicine, 57, 518. https://doi.org/10.1097/ JOM.0000000000000454
• Grevenstein, D., Nagy, E. y Kroeninger-Jungaberle, H. (2015). Development of risk perception and substance use of tobacco, alcohol and cannabis among adolescents and emerging adults: evidence of directional influences. Substance Use & Misuse, 50, 376–386. https://doi.org/10.3109/1 0826084.2014.984847
• Haas, A. L. y Peters, R. H. (2000). Development of substance abuse problems among drug-involved offenders: Evidence for the telescoping effect. Journal of substance abuse, 12(3), 241-253.
• Hall, W., Degenhardt, L. y Teesson, M. (2009). Reprint of “Understanding comorbidity between substance use, anxiety and affective disorders: Broadening the research base”. Addictive Behaviors, 34, 795-799. https://doi.org/10.1016/j. addbeh.2009.03.040
• Hancock-Allen, J. B., Barker, L., VanDyke, M. y Holmes, D. B. (2015). Death following ingestion of an edible marijuana product—Colorado, March 2014. MMWR. Morbidity and Mortality Weekly Report, 64, 771. https://doi.org/10.15585/mmwr. mm6428a6
• Hart-Hargrove, L. C. y Dow-Edwards, D. L. (2012). Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. Behavioural Brain Research, 231, 48–59. https://10.1016/j. bbr.2012.02.048
• Hazekamp, A., Ware, M. A., Muller-Vahl, K. R., Abrams, D. y Grotenhermen, F. (2013). The medicinal use of cannabis and cannabinoids—an international cross-sectional survey on administration forms. Journal of Psychoactive Drugs, 45, 199-210. https://doi.org/10.1080/0279 1072.2013.805976
• Hemsing, N. y Greaves, L. (2020). Gender norms, roles and relations and cannabisuse patterns: a scoping review. International journal of environmental research and public health, 17(3), 947. https://doi. org/org/10.3390/ijerph17030947
• Hernandez-Avila, C. A., Rounsaville, B. J. y Kranzler, H. R. (2004). Opioid-, cannabisand alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and alcohol dependence, 74(3), 265-272.
• Herrmann, E. S., Weerts, E. y Vandrey, R. (2015). Gender differences in cannabis withdrawal symptoms among treatmentseeking cannabis users. Drug and Alcohol Dependence, 100(156), e95.
• Hindley, G., Beck, K., Borgan, F., Ginestet, C. E., McCutcheon, R., Kleinloog, D., ... & Howes, O. D. (2020). Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry, 7(4), 344-353.
• Isorna, M. y Arias, F. (2022). Una aproximación al panorama actual de las nuevas formas de consumo de drogas. Adicciones, 34, 3-12. https://doi.org/10.20882/ adicciones.1787
• Isorna, M., Villanueva, V., Veiga, S. y Otero, M. (2020). Formas de consumo del cannabis: Características, riesgos y daños asociados. En M. Isorna, A. Rial y V. Villanueva (Eds.), Cannabis: Evidencia científica vs controversia social (pp. 59-101). Dykinson, S.L
• Legleye, S., Karila, L., Beck, F. y Reynaud, M. (2007). Validation of the CAST, a general population Cannabis Abuse Screening Test. Journal of substance use, 12(4), 233-242. https://doi. org/10.1080/14659890701476532
• Legleye, S., Piontek, D. y Kraus, L. (2011). Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents. Drug and Alcohol Dependence, 113, 229–235. https://doi.org/10.1016/j.drugalcdep.2010.08.011
• López-Pelayo, H., De Montagut, L. M., Kögel, C. C. y Oliveró, M. B. (2018). Posverdad del consumo de cannabis: de regreso a la medicina basada en la evidencia Posttruth Cannabis use: back to evidencebased medicine. Adicciones, 30(4), 237- 242. https://doi.org/10.20882/adicciones.30.4
• Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M. y Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin, 42, 1262-1269. https:// doi.org/10.1093/schbul/sbw003
• Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S., … Moffitt, T. E. (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the Nacional Academy of Sciences of the United States of America, 109, E2657-E2664. https://doi.org/10.1073/ pnas.1206820109
• Míguez M.C. y Permuy B. (2017) Características del alcoholismo en mujeres. Revista Facultad de Medicina, 65, 15-22. https://doi.org/10.15446/revfacmed. v65n1.57482
• Murray, R. M., Quigley, H., Quattrone, D., Englund, A. y Di Forti, M. (2016). Traditional marijuana, high-potency cannabis and synthetic cannabinoids: Increasing risk for psychosis. World Psychiatry, 15, 195–204. https://doi.org/10.1002/wps.20341
• National Academies of Sciences, Engineering, and Medicine [NASEM] (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. The National Academies Press. https://doi.org/10.17226/24625
• Observatorio Español de las Drogas y las Adicciones. (2022a). Informe 2022. Alcohol, tabaco y drogas ilegales en España. Ministerio de Sanidad. Delegación del Gobierno para el Plan Nacional sobre Drogas, 293p. https://pnsd.sanidad.gob. es/profesionales/sistemasInformacion/ informesEstadisticas/pdf/2022OEDAINFORME.pdf
• Observatorio Español de las Drogas y las Adicciones. (2022b). Monografía Cannabis 2022. Consumo y consecuencias. Ministerio de Sanidad. Delegación del Gobierno para el Plan Nacional sobre Drogas.
• Observatorio Europeo de las Drogas y las Toxicomanías (2022). Informe Europeo sobre Drogas 2022: Tendencias y novedades. Oficina de Publicaciones de la Unión Europea.
• Oeltmann, J. E., Oren, E., Haddad, M. B., Lake, L. K., Harrington, T. A., Ijaz, K. y Narita, M. (2006). Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerging Infectious Diseases, 12, 1156. https://doi.org/10.3201/ eid1207.051436
• Olano, E., Lozano, A., Guàrdia, M. G., Ogué, M. C. P., Isorna, M. y Arnedillo, J. J. M. (2020). ¿Por qué y cómo tener en cuenta al cannabis en nuestros pacientes fumadores? Atención Primaria, 52(1), 47-53. https://doi.org/10.1016/j. aprim.2018.05.014
• Orr, C., Spechler, P., Cao, Z., Albaugh, M., Chaarani, B., Mackey, S., ... y Garavan, H. (2019). Grey matter volume differences associated with extremely low levels of cannabis use in adolescence. Journal of Neuroscience, 39(10), 1817-1827. https:// doi.org/10.1177/0269881119841568
• Papaseit, E., Pérez-Mañá, C., Pérez-Acevedo, A. P., Hladun, O., Torres-Moreno, M. C., Muga, R., ... & Farre, M. (2018). Cannabinoids: from pot to lab. International journal of medical sciences, 15(12), 1286. https://doi.org/10.7150/ijms.27087
• Patton, G. C., Coffey, C., Carlin, J. B., Sawyer, S. M. y Lynskey, M. (2005). Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction, 100(10), 1518- 1525.
• Perlman, D. C., Perkins, M. P., Paone, D., Kochems, L., Salomon, N., Friedmann, P. y Des Jarlais, D. C. (1997). “Shotgunning” as an illicit drug smoking practice. Journal of Substance Abuse Treatment, 14, 3-9. https://doi.org/10.1016/S0740- 5472(96)00182-1
• Piazza, N. J., Vrbka, J. L. y Yeager, R. D. (1989). Telescoping of alcoholism in women alcoholics. International Journal of the Addictions, 24(1), 19-28.
• Pinto, J. V., Medeiros, L. S., da Rosa, G. S., de Oliveira, C. E. S., de Souza Crippa, J. A., Passos, I. C. y Kauer-Sant’Anna, M. (2019). The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with metaanalysis and meta-regression. Neuroscience & Biobehavioral Reviews, 101, 78-84.
• Potter, D. J., Hammond, K., Tuffnell, S., Walker, C. y Di Forti, M. (2018). Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology. Drug Testing and Analysis, 10, 628-635. https://doi.org/10.1002/ dta.2368
• Power RA, Verweij KJ, Zuhair M, Montgomery GW, Henders AK, Heath AC, et al. (2014). Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry, 19(11), 1201-1204. https://doi.org/10.1038/ mp.2014.51
• Raber, J. C., Elzinga, S. y Kaplan, C. (2015). Understanding dabs: Contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. The Journal of Toxicological Sciences, 40, 797-803. https://doi.org/10.2131/ jts.40.797
• Ramos, J. (2017). Efectos terapéuticos de los cannabinoides. Instituto universitario de Investigación en Neuroquímica de la Universidad Complutense de Madrid.
• Rial, A., Burkhart, G., Isorna, M., Barreiro, C., Varela, J. y Golpe, S. (2019). Consumo de cannabis entre adolescentes: patrón de riesgo, implicaciones y posibles variables explicativas [Cannabis use among adolescents: risk pattern, implications and possible explicative variables]. Adicciones, 31(1), 64–77. https://doi. org/10.20882/adicciones.1212
• Rial, A., García-Couceiro, N., Gómez, P., Mallah, N., Varela, J., Flórez-Menéndez, G. y Isorna, M. (2022). Psychometric properties of CAST for early detection of problematic cannabis use in Spanish adolescents. Addictive behaviors, 129, 107288. https://doi.org/10.1016/j. addbeh.2022.107288
• Santos-Álvarez, I., Pérez-Lloret, P., GonzálezSoriano, J. y Pérez-Moreno, M. (2021). Aproximación a la evaluación de la potencia de la resina de cannabis en Madrid: ¿Un riesgo para la salud? Adicciones. https:// doi.org/10.20882/adicciones.1630
• Schlienz, N. J., Budney, A. J., Lee, D. C. y Vandrey, R. (2017). Cannabis withdrawal: A review of neurobiological mechanisms and sex differences. Current Addiction Reports, 4, 75–81. https://doi. org/10.1007/s40429-017-0143-1
• Sherman, B. J., Baker, N. L. y McRae-Clark, A. L. (2016). Gender differences in cannabis use disorder treatment: change readiness and taking steps predict worse cannabis outcomes for women. Addictive behaviors, 60, 197-202. https://doi.org/10.1016/j. addbeh.2016.04.014
• Stephens, D., Patel, J. K., Angelo, D. y Frunzi, J. (2020). Cannabis butane hash oil dabbing induced lung injury mimicking atypical pneumonia. Cureus, 12. https://doi. org/10.7759/cureus.7033
• Stogner, J. M. y Miller, B. L. (2015). The dabbing dilemma: A call for research on butane hash oil and other alternate forms of cannabis use. Substance Abuse, 36, 393- 395. https://doi.org/10.1080/0889707 7.2015.1071724
• Tetrault, J. M. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167, 221. https://doi.org/10.1001/archinte.167.3.221
• Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., González, R.,… Baler, R. (2016). Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry, 73, 292-297. https:// doi.org/10.1073/pnas.1411228111
• Welsh, C., Goldberg, R., Tapscott, S., Medoff, D., Rosenberg, S. y Dixon, L. (2012). “Shotgunning” in a population of patients with severe mental illness and comorbid substance use disorders. The American Journal on Addictions, 21, 120- 125. https:///doi.org/10.1111/j.1521- 0391.2011.00201.x
• Wiers, C. E., Shokri-Kojori, E., Wong, C. T., Abi-Dargham, A., Demiral, Ş. B., Tomasi, D., ... & Volkow, N. D. (2016). Cannabis abusers show hypofrontality and blunted brain responses to a stimulant challenge in females but not in males. Neuropsychopharmacology, 41(10), 2596-2605.
• World Health Organization (2016). Health and Social Effects of Nonmedical Cannabis Use (The). World Health Organization. https://www.who.int/ publications/i/item/9789241510240